Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
N/A
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
0.12
PEG RATIO AVG 5Y
0.31
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.30B | N/A | N/A | 0.12 | 0.31 |
| NRC Health (NRC)vs › | $458.40M | N/A | 2.52 | 3.04 | 2.90 |
| Shoulder Innovations, Inc. (SI)vs › | $427.00M | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.43B | N/A | 0.12 | 0.27 | 0.46 |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | 0.00 | 0.00 | 0.31 |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 0.05 | 0.05 | 1.65 | 1.32 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.05B | N/A | 0.84 | 0.69 | 0.69 |
| Oscar Health, Inc. (OSCR)vs › | $7.23B | 0.01 | 0.01 | 0.07 | 0.12 |
| Tempus AI, Inc. (TEM)vs › | $9.12B | N/A | 0.60 | 1.25 | 1.25 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | N/A | 0.10 | 0.17 | 0.14 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 0.08 |
| 2023-12-31 | 0.16 |
| 2021-12-31 | 0.69 |
| 2019-12-31 | 9.91 |
| 2018-12-31 | 1.41 |
| 2016-12-31 | 0.24 |
